nimorazole has been researched along with Benign Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, SW; Fatima, N; Hameed, A; Jabeen, A; Qazi, AS; Safdar, W; Tariq, MR | 1 |
| Denifl, S; Fárník, M; Fedor, J; Feketeová, L; Illenberger, E; Kočišek, J; Limão-Vieira, P; Meißner, R | 1 |
| Hirst, DG | 1 |
| Overgaard, J; Overgaard, M; Timothy, AR | 2 |
| Shibamoto, Y | 1 |
| Dische, S | 1 |
| Ahmed, F; Arai, MA; Ishibashi, M; Sadhu, SK; Yoneyama, T | 1 |
2 review(s) available for nimorazole and Benign Neoplasms
| Article | Year |
|---|---|
[Contribution of radiation biology to the development of radiation therapy].
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Dose Fractionation, Radiation; Humans; Imidazoles; Lung Neoplasms; Neoplasms; Nimorazole; Radiation-Sensitizing Agents; Triazoles | 1999 |
Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy.
Topics: Adrenal Cortex Hormones; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Etanidazole; Humans; Metronidazole; Misonidazole; Neoplasms; Nimorazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1985 |
1 trial(s) available for nimorazole and Benign Neoplasms
| Article | Year |
|---|---|
Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy.
Topics: Adrenal Cortex Hormones; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Etanidazole; Humans; Metronidazole; Misonidazole; Neoplasms; Nimorazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1985 |
6 other study(ies) available for nimorazole and Benign Neoplasms
| Article | Year |
|---|---|
Radiation Therapies in Cancer.
Topics: Gemcitabine; Humans; Immunotherapy; Mitomycin; Neoplasms; Nimorazole | 2023 |
Low-energy electrons transform the nimorazole molecule into a radiosensitiser.
Topics: Chemoradiotherapy; Electrons; Humans; Neoplasms; Nimorazole; Oxidation-Reduction; Radiation-Sensitizing Agents | 2019 |
The importance of radiobiology to cancer therapy: current practice and future perspectives.
Topics: Carbon Dioxide; Cell Proliferation; Chemotherapy, Adjuvant; Dose Fractionation, Radiation; Humans; Hyperthermia, Induced; Neoplasms; Nimorazole; Oxygen; Radiation-Sensitizing Agents; Radiobiology; Radiotherapy, Adjuvant | 2007 |
A phase I clinical study of Nimorazole as a hypoxic radiosensitizer.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Nimorazole; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors | 1984 |
Studies of the pharmacokinetic properties of nimorazole.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Intestinal Absorption; Male; Middle Aged; Neoplasms; Nimorazole; Nitroimidazoles; Time Factors | 1983 |
Hedgehog inhibitors from Withania somnifera.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Female; Hedgehog Proteins; Humans; Male; Neoplasms; Signal Transduction; Withania; Withanolides | 2015 |